Discovery of Daclatasvir as a potential PD-L1 inhibitor from drug repurposing.
Release Time:2024-11-12 Hits:
Date of Publication: 2024-11-08
Journal: Bioorganic chemistry
Volume: 153
Page Number: 107874
ISSN: 0045-2068
Key Words: 3D QSAR Pharmacophore model; Daclatasvir; Drug repurposing; Lenvatinib; Molecular Docking; PD-L1 small molecular inhibitor